Related Experiment Video
Updated: Jun 20, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Changing epidemiology of an emerging infection: zygomycosis
1Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. j.meis@cwz.nl
Abstract:
Aspergillosis and candidosis remain the most prevalent opportunistic fungal infections in immunocompromised patients, but diseases caused by the Zygomycetes have become of increasing importance. Exposure to antimycotic drugs with no activity against zygomycetes may be a new risk factor and an explanation for the increasing incidence of zygomycosis. The latter infection occurs only rarely in immunocompetent hosts, but in recent years Apophysomyces elegans has been described in many subtropical countries as an emerging pathogen causing mostly cutaneous infections after traumatic inoculation.
Insights
Zygomycetes infections are rising in importance, potentially due to antifungal drug resistance. Apophysomyces elegans is an emerging fungal pathogen causing skin infections, particularly in subtropical regions.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Aspergillosis and candidosis are common opportunistic fungal infections in immunocompromised individuals.
- Diseases caused by Zygomycetes are increasingly significant.
- Exposure to certain antimycotic drugs may be a risk factor for zygomycosis.
Purpose of the Study:
- To highlight the increasing importance of Zygomycetes as pathogens.
- To identify potential risk factors for zygomycosis, such as exposure to specific antifungal drugs.
- To describe the emergence of Apophysomyces elegans as a pathogen, particularly in subtropical regions.
Main Methods:
- Literature review and analysis of epidemiological data on fungal infections.
- Review of clinical case studies and reports on Zygomycetes and Apophysomyces elegans.
- Analysis of the impact of antifungal drug resistance on the incidence of zygomycosis.
Main Results:
- Zygomycetes infections are becoming more prevalent.
- Antimycotic drugs lacking activity against Zygomycetes may contribute to increased zygomycosis incidence.
- Apophysomyces elegans is an emerging pathogen causing cutaneous infections, especially after trauma in subtropical areas.
Conclusions:
- The rise in zygomycosis incidence may be linked to antifungal treatment choices.
- Apophysomyces elegans represents a growing concern for cutaneous infections in specific geographic areas.
- Further research is needed to understand and manage Zygomycetes infections effectively.
Related Concept Videos
Fungal Group Zygomycota
Cryptococcal Meningitis
Infectious Diseases and Their Occurrence
Fungal Phylum Microsporidia
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Toxoplasmosis
